Efficacy of gefitinib or erlotinib in patients with squamous cell lung cancer

INTRODUCTION: The aim of this study was to evaluate the feasibility of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) and EGFR mutation frequency in advanced squamous cell lung cancer based on the data from our hospital. MATERIAL AND METHODS: The clinical data of 102 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Zhengbo, Zhang, Yiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2013
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379363/
https://www.ncbi.nlm.nih.gov/pubmed/25861304
http://dx.doi.org/10.5114/aoms.2013.39234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379363/
https://www.ncbi.nlm.nih.gov/pubmed/25861304
http://dx.doi.org/10.5114/aoms.2013.39234

Ejemplares similares